SER - Serina Therapeutics, Inc.
5.63
-0.115 -2.048%
Share volume: 3,060
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$5.75
-0.12
-0.02%
Summary score
48%
Profitability
68%
Dept financing
50%
Liquidity
44%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
21.93%
Return on assets
-50.77%
Return on sales
-15054.72%
Return on invested capital
19.28%
Total debt ratio
349.67%
Debt ratio change over timeo
10.17%
Current Ratio
0.53%
Quick Ratio
0.23%
Cash Position Ratio
0.33%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-96.5%
Return on sales
39635.71%
Return on invested capital
0%
Total debt ratio
82.6%
Debt ratio change over timeo
0%
Current Ratio
2.42%
Quick Ratio
0%
Cash Position Ratio
1.68%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-71.64%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
74.73%
Debt ratio change over time
0%
Current Ratio
2.45%
Quick Ratio
0%
Cash Position Ratio
1.81%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-107.05%
Return on assets
-221.87%
Return on sales
-37801.47%
Return on invested capital
-65.01%
Total debt ratio
1016.6%
Debt ratio change over time
10.17%
Current Ratio
-0.57%
Quick Ratio
-0.57%
Cash Position Ratio
-0.91%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SER | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 21.93% | 14.28% | 9.23% | 0% |
| Return on assets | -50.77% | 4.23% | 3.2% | 0% |
| Return on sales | -15054.72% | 27.89% | 25.03% | 0% |
| Return on invested capital | 19.28% | 8.36% | 9.37% | 0% |
| Profitability | 50% | 77% | 64% | 0% |
| Total debt ratio | 349.67% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | 10.17% | -11.36% | -57.43% | 0% |
| Dept financing | 50% | 6% | 4% | 0% |
| Current Ratio | 2.42% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 1.68% | 0.12% | 0.5% | 0% |
| Liquididy | 31% | 55% | 75% | 0% |
| Short-term ratios | SER | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -96.5% | 4.32% | 3.49% | 0% |
| Return on sales | 39635.71% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 75% | 25% | 20% | 0% |
| Total debt ratio | 82.6% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 25% | 18% | 0% |
| Current Ratio | 2.42% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 1.68% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 39% | 42% | 0% |
